Major pharmaceutical firms fare ill in 1Q

Korea's major drug firms performed worse in the first quarter of 2012 than three months earlier largely due to quick handling of their drug inventories to soften the impact from the government-mandated cuts in drug prices, data showed Monday.

According to the data compiled by brokerage houses, the first-quarter overall sales of drug companies are forecast to inch up while their operating pro...